Venture capital funding of the InsurTech sector is showing signs of stabilization and is expected to reach $4.2 billion by the end of 2024, returning to levels not seen since 2018.
The third quarter of 2024 ended with investments of $3.2 billion, which is 7% less than in the same period of 2023. However, this decline is considered temporary, and the positive trend indicates a possible recovery in the last quarter.
The recovery in funding is mainly driven by Series B and C companies, which are approaching pre-pandemic levels of investment. Meanwhile, early-stage startups (pre-seed, seed, and Series A) are also contributing to this stabilization, although their funding is down 50% from the peaks of 2021. At the same time, late-stage startups are struggling, with funding down nearly 90% from 2021 levels, reflecting broader market caution toward mature companies with high valuations.